Treatment of allergic rhinitis with probiotics: An alternative approach

North American Journal of Medical Sciences

Volumn 5, Issue 8, 2013, Pages 465-468

  Yang, Gui ^a   Liu, Zhi Qiang ^a   Yang, Ping Chang ^b  

^a Longgang Central Hospital   (China)

^b Shenzhen University School of Medicine   (China)

Author keywords

Allergy rhinitis; Bacteria; Mechanism; Probiotics; Theurapeutics

Indexed keywords

BIFIDOBACTERIUM ANIMALIS EXTRACT; ESCHERICHIA COLI NISSLE EXTRACT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS EXTRACT; LACTOBACILLUS GASSERI EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; LACTOBACILLUS REUTERI EXTRACT; OVALBUMIN; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VSL3;

ALLERGIC RHINITIS; ATOPY; BACTEREMIA; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIZATION; ECOSYSTEM; FOOD ALLERGY; FUNGEMIA; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNE RESPONSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR DOWN REGULATION; REVIEW; SEPTICEMIA; SIDE EFFECT; SUPPLEMENTATION; WHEEZING;

EID: 84883312677     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.117299     Document Type: Review

References (39)

1. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry crosssectional surveys. Lancet 2006;368:733-43.
2. Nurmatov U, van Schayck CP, Hurwitz B, Sheikh A. House dust mite avoidance measures for perennial allergic rhinitis: An updated Cochrane systematic review. Allergy 2012;67:158-65.
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-62.
4. Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol 2011;27:496-501.
5. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A double-blind, placebo-controlled study. J Dairy Sci 2005;88:527-33.
6. Yonekura S, Okamoto Y, Okawa T, Hisamitsu M, Chazono H, Kobayashi K, et al. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis. Allergy Asthma Proc 2009;30:397-405.
7. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004;15:152-8.
8. Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005;16:433-8.
9. Wassenberg J, Nutten S, Audran R, Barbier N, Aubert V, Moulin J, et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy 2011;41:565-73.
10. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV, et al; Felicita Study Group. A randomized prospective double blind controlled trial on effects of longterm consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007;62:215-20.
11. Tamura M, Shikina T, Morihana T, Hayama M, Kajimoto O, Sakamoto A, et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: Randomized double-blind, placebo-controlled clinical trial. Int Arch Allergy Immunol 2007;143:75-82.
12. Ivory K, Chambers SJ, Pin C, Prieto E, Arques JL, Nicoletti C. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 2008;38:1282-9.
13. Koyama T, Kirjavainen PV, Fisher C,Anukam K, Summers K, Hekmat S, et al. Development and pilot evaluation of a novel probiotic mixture for the management of seasonal allergic rhinitis. Can J Microbiol 2010;56:730-8.
14. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study. Allergy 2002;57:243-6.
15. Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, et al. Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 2006;36:1425-35.
16. Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized doubleblind, placebo-controlled trial. J Investig Allergol Clin Immunol 2006;16:86-93.
17. Xiao JZ, Kondo S, Takahashi N,Odamaki T, Iwabuchi N, Miyaji K, et al. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Int Arch Allergy Immunol 2007;144:123-7.
18. Xiao JZ, Kondo S, Yanagisawa N, Miyaji K, Enomoto K, Sakoda T, et al. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int 2007;56:67-75.
19. Lue KH, Sun HL, Lu KH, Ku MS, Sheu JN, Chan CH, et al. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12years. Int J Pediatr Otorhinolaryngol 2012;76:994-1001.
20. Morita H, He F, Kawase M, Kubota A, Hiramatsu M, Kurisaki J, et al. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol Immunol 2006;50:701-6.
21. Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 2010;45:1111-20.
22. Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA. Bacillus clausii effects in children with allergic rhinitis. Allergy 2005;60:702-3.
23. Bickert T, Trujillo-Vargas CM, Duechs M, Wohlleben G, Polte T, Hansen G, et al. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int Arch Allergy Immunol 2009;149:219-30.
24. Kawase M, He F, Kubota A, Hiramatsu M, Saito H, Ishii T, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebocontrolled clinical study. Int J Food Microbiol 2009;128:429-34.
25. Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009;15:3261-8.
26. Di FG, Barletta B, Butteroni C, Corinti S, Tinghino R, Colombo P, et al. Use of probiotic bacteria for prevention and therapy of allergic diseases: Studies in mouse model of allergic sensitization. J Clin Gastroenterol 2008;42 Suppl 3:S130-2.
27. Meijerink M, Wells JM, Taverne N, de Zeeuw Brouwer ML, Hilhorst B, Venema K et al. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol Med Microbiol 2012;65:488-96.
28. Ozdemir O. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin Exp Immunol 2010;160:295-304.
29. Ridwan BU, Koning CJ, Besselink MG, Timmerman HM, Brouwer EC, Verhoef J, et al. Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis. Lett Appl Microbiol 2008;46:61-7.
30. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al; Acute Pancreatitis Werkgroep Nederland. Probiotic prophylaxis in patients with predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Ned Tijdschr Geneeskd 2008;152:685-96.
31. Snydman DR. The safety of probiotics. Clin Infect Dis 2008;46 Suppl 2:S104-11.
32. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38:457-8.
33. Salminen S, von WA, Morelli L, Marteau P, Brassart D, de Vos WM et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998;44:93-106.
34. Egervarn M, Roos S, Lindmark H. Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum. J Appl Microbiol 2009;107:1658-68.
35. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e850-6.
36. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-34.
37. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007;119:184-91.
38. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008;46 Suppl 2:S87-91.
39. Kandasamy M, Selvakumari JA, Moochhala S, Huat BB, Kun LY, Mahendran R. Lactobacillus rhamnosus GG secreting an antigen and Interleukin-2 translocates across the gastrointestinal tract and induces an antigen specific immune response. Microbiol Immunol 2011;55:704-14.